MedPath

Multicenter, randomized, controlled trial comparing complication rates of open and closed implantation strategies for insertion of a totally implantable venous access port (TIVAP) in oncological patients

Not Applicable
Conditions
OPS 5-399.5 - implantation and change of a permanent venous catheter (e.g. for chemotherapy or analgesia
J93
Pneumothorax
Registration Number
DRKS00004900
Lead Sponsor
Klinik für Allgemein,- Viszeral,- und Transplantationschirurgie, Chirurgische Universitätsklinik Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
1205
Inclusion Criteria

1.Patient with oncological disease
2.scheduled for elective implantation of TIVAP
3.primary implantation on the designated side
4.Ability of subject to understand character and individual consequences of the clinical trial
5.Written informed consent

Exclusion Criteria

1.participation in another clinical trial which could interfere with the primary endpoint of this study
2.impaired mental state or language problems

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of pneumo-/hemothorax after TIVAP implantation diagnosed by means of a chest x-ray on the day of operation. Telephone interview on postoperative day 30
Secondary Outcome Measures
NameTimeMethod
- Primary success rates<br>- quality of life (EQ 5-D)<br>- duration of intervention<br>- mortality and morbidity until day 30. <br><br>Assessment on day of operation and standardized telephone interview on day 30 post-OP
© Copyright 2025. All Rights Reserved by MedPath